Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 383,221 | 128,030 | 393,644 | 595,082 | 7,227 |
| Marketable Securities | 98,956 | 128,519 | N/A | N/A | N/A |
| Receivables | 43,768 | 37,818 | 24,166 | 15,392 | 2,633 |
| TOTAL | $536,409 | $315,092 | $437,747 | $628,774 | $11,165 |
| Non-Current Assets | |||||
| PPE Net | 744 | 1,039 | 1,168 | 162 | N/A |
| Other Non-Current Assets | 39,645 | 44,115 | 5,392 | 699 | 552 |
| TOTAL | $40,389 | $45,154 | $6,560 | $861 | $552 |
| Total Assets | $576,798 | $360,246 | $444,307 | $629,635 | $11,717 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 5,627 |
| Accounts payable and accrued liabilities | 7,143 | 11,815 | 13,836 | 8,065 | 1,032 |
| Accrued Expenses | 50,855 | 27,570 | 24,502 | 16,573 | 1,047 |
| Other current liabilities | N/A | N/A | N/A | N/A | 913 |
| TOTAL | $57,998 | $39,385 | $38,338 | $24,638 | $8,619 |
| Non-Current Liabilities | |||||
| Long Term Debt | 108,940 | 75,700 | 69,800 | 75,700 | N/A |
| Other Non-Current Liabilities | 8,315 | 8,917 | 0 | 37,743 | 0 |
| TOTAL | $117,255 | $84,617 | $69,800 | $113,443 | $N/A |
| Total Liabilities | $175,253 | $124,002 | $108,138 | $138,081 | $8,619 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 133,184 | 100,306 | 94,961 | 94,020 | N/A |
| Common Shares | 359 | 273 | 265 | 252 | N/A |
| Retained earnings | -988,702 | -752,945 | -601,860 | -385,653 | -22,423 |
| Other shareholders' equity | 4,213 | 1,493 | -1,497 | 688 | 0 |
| TOTAL | $401,545 | $236,244 | $336,169 | $491,554 | $3,098 |
| Total Liabilities And Equity | $576,798 | $360,246 | $444,307 | $629,635 | $11,717 |